|
HS Code |
842436 |
| Chemical Formula | C7H4ClNS |
| Molar Mass | 169.63 g/mol |
| Appearance | Solid |
| Color | Typically colorless to pale yellow |
| Odor | May have a characteristic odor |
| Melting Point | Varies, around [specific value if known] °C |
| Boiling Point | Varies, around [specific value if known] °C |
| Solubility In Water | Low solubility |
| Solubility In Organic Solvents | Soluble in some organic solvents like ethanol, acetone |
| Density | [Value if known] g/cm³ |
| Stability | Stable under normal conditions, may react with strong oxidants |
As an accredited 2-Chloro-1,3-Benzothiazole factory, we enforce strict quality protocols—every batch undergoes rigorous testing to ensure consistent efficacy and safety standards.
| Packing | 250g of 2 - Chloro - 1,3 - Benzothiazole packaged in a sealed chemical - grade bottle. |
| Shipping | 2 - Chloro - 1,3 - benzothiazole is a chemical. Ship it in properly sealed, corrosion - resistant containers. Ensure compliance with hazardous chemical shipping regulations, with appropriate labeling for safe transportation. |
| Storage | 2 - Chloro - 1,3 - benzothiazole should be stored in a cool, dry, well - ventilated area. Keep it away from heat sources, open flames, and oxidizing agents. Store in a tightly sealed container to prevent leakage and exposure to air and moisture, which could potentially lead to degradation or reaction. Avoid storing near incompatible substances to ensure safety. |
|
In a standard sulfenamide accelerator production campaign, 2-chloro-1,3-benzothiazole (assay ≥99.0% by GC, moisture ≤0.1% w/w) is suspended in demineralised water at a w/v ratio of 1:4 within a 3,000 L glass-lined reactor equipped with a retreat-curve impeller rotating at 90–110 rpm. Cyclohexylamine (1.05 molar equivalents relative to 2-Cl-BT) is injected over 45–60 min while the jacket temperature is ramped from 25°C to 40°C. The pH is brought to 10.5–11.0 by simultaneous addition of 30% sodium hydroxide solution through a dosage ring, and the exotherm is moderated to keep the internal temperature below 50°C; excursion above 52°C promotes hydrolysis to 2-hydroxybenzothiazole, a contaminant that shortens Mooney scorch time in rubber stocks by 15–25% at 0.2% inclusion. After 4 h stirring, GC analysis (DB-5, 30 m × 0.25 mm, FID) confirms residual 2-chloro starting material <0.15% area. The crude N-cyclohexyl-2-benzothiazolesulfenamide (CBS) is isolated via pressure nutsche filtration at 0.35 MPa N2, washed with warm water (50°C) until chloride ion in the filtrate drops below 50 ppm (AgNO3 turbidimetric test), and vacuum-dried at 60°C and ≤−0.09 MPa to a final moisture content ≤0.15%. The dried product exhibits a melting point of 96–98°C, purity >99.2% via HPLC (C18, acetonitrile/water 70:30, UV 254 nm), and bulk density 0.48–0.52 g/cm³. CBS acts as a delayed-action primary accelerator in natural rubber, SBR, and BR compounds; in a typical silica-filled passenger tyre tread formulation, it is dosed at 1.2–1.8 phr alongside 2.5 phr sulfur, 0.3 phr diphenylguanidine, and 50 phr highly dispersible silica. The Mooney scorch time at 121°C per ASTM D1646 extends beyond 35 min, while the moving-die rheometer t90 at 160°C (ASTM D5289, 0.5° arc) falls in the 5.0–6.5 min range, balancing long flow safety with rapid final crosslink development. For EU food-contact rubber articles, compliance with Regulation (EU) No 10/2011 and BfR Recommendation XXI demands specific migration of cyclohexylamine below 0.01 mg/kg food simulant and total primary aromatic amines below the 0.01 mg/kg detection limit, verified by LC-MS/MS after 40°C/10 days migration testing. Under REACH (EC) 1907/2006, CBS is registered as a skin sensitiser Category 1 (H317); finished articles containing CBS must not release the substance at a rate that yields a dermal exposure exceeding 0.1% w/w classification cut-off.
What Limits the Disulfide Formation Rate When Aqueous Na2S2 Replaces Polysulfide Reagents?2-Chloro-1,3-benzothiazole undergoes oxidative dimerization to 2,2′-dibenzothiazyl disulfide (MBTS) when treated with sodium disulfide generated in situ from sodium sulfide nonahydrate and sulfur (molar ratio Na2S·9H2O : S = 1 : 1.05) in water at 70–80°C. The stoichiometric demand is precisely 2 mol of the chlorinated heterocycle per 1 mol of Na2S2. In a 5,000 L stainless-steel reactor, 250 kg (1,479 mol) of 2-Cl-BT is dispersed in 1,200 L water containing 0.2% w/w sodium lauryl sulfate as a wetting agent; the Na2S2 solution (740 mol active S22−) is added dropwise over 2 h while maintaining the temperature at 78±2°C. Air sparging at 1.5 Nm³/h through a bottom sparger ring enhances mass transfer and drives the oxidation of intermediate mercaptide to the disulfide; the off-gas is scrubbed with 10% NaOH to remove any H2S. End-point determination relies on HPLC monitoring of residual 2-Cl-BT (<0.3% area). The slurry is cooled to 20°C, acidified with 30% H2SO4 to pH 3.5–4.0 to precipitate MBTS, filtered through a polypropylene plate-and-frame filter press, washed with demineralised water until conductivity falls below 100 μS/cm, and dried in a fluidised-bed dryer at inlet air temperature 80°C to a moisture content ≤0.3%. Commercial MBTS appears as a pale-yellow powder, melting range 178–186°C, purity >96.5% (HPLC), and ash <0.3%. As a medium-fast primary accelerator, MBTS finds use in thick-walled mechanical rubber goods such as engine mounts and bridge bearings, where its scorch time (Mooney t5 at 121°C typically 15–22 min at 1.5 phr loading) provides a narrower processing safety margin than sulfenamides but permits lower cure temperatures (140°C). Regulatory alignment for MBTS parallels that of CBS under REACH and the same food-contact migration limits, with the additional requirement that batch certificates report free 2-mercaptobenzothiazole (2-MBT) content <0.5% because 2-MBT is classified as a respiratory sensitiser under CLP Regulation (EC) No 1272/2008 (H334). The MDR cure curve of an NR/SBR compound containing 1.5 phr MBTS and 2.0 phr sulfur reveals a minimum torque ML of 1.8 dNm and maximum MH 12.3 dNm at 150°C. Pre-drying of the accelerator is mandated whenever relative humidity in the storage area exceeds 60%; agglomerates formed during ocean shipment are breakable with a 500 μm sieve prior to internal mixing. Surrogate Parameters for Alkylation Efficiency: Potassium Carbonate Particle Size and Water Content in Mefenacet SynthesisProduction of the pre-emergence herbicide mefenacet [2-(1,3-benzothiazol-2-yloxy)-N-methyl-N-phenylacetamide] proceeds via O-alkylation of N-methylhydroxyacetanilide (NMHA) with 2-chloro-1,3-benzothiazole in anhydrous N,N-dimethylformamide (DMF, water <0.05%) at 80–85°C for 6–8 h using 1.20−1.25 molar equivalents of ground potassium carbonate (325 mesh, D50 15 μm) as acid scavenger. A typical batch charges 1.0 kmol of 2-Cl-BT, 1.08 kmol of NMHA, and 1.22 kmol of K2CO3 into 2,500 L of DMF; agitation is set to 150 rpm via a pitched-blade turbine. The reaction progress is tracked by TLC (silica, ethyl acetate/hexane 1:1) with a target of <1% residual NMHA. Upon completion, the mixture is cooled to 10°C, quenched with 3,000 L ice-water, and the crude mefenacet is collected by centrifugation (1,200 G), washed with cold water, and recrystallised from isopropanol (1:3 w/v) to afford white crystals with m.p. 132–134°C and technical purity >98.5% (HPLC, UV 230 nm). The finished technical grade is formulated as a 500 g/L suspension concentrate (SC) or 10% wettable powder (WP) for application in paddy rice at rates of 300–600 g a.i./ha. Under Regulation (EC) No 1107/2009, the active substance specification mandates limits for relevant impurities: 2-chlorobenzothiazole <1 g/kg, NMHA <0.5 g/kg, and DMF <0.1% w/w as residual solvent (ICH Q3C Class 2). The maximum residue limit (MRL) for mefenacet in rice has been set at 0.01 mg/kg in the EU per Regulation (EC) No 396/2005 (Annex III), and the compound is not approved for use on crops intended for infant food (Directive 2006/125/EC). Production equipment requires passivation of stainless-steel surfaces with 3% citric acid prior to first batch after maintenance to prevent iron-catalysed hydrolysis of 2-Cl-BT to 2-hydroxybenzothiazole, which would otherwise form the corresponding ether impurity. The SC formulation must pass CIPAC MT 184 (suspensibility) and MT 148 (persistent foam) tests for product registration.
For the construction of 2-hydrazinyl-1,3-benzothiazole — a versatile intermediate en route to triazolobenzothiazoles with reported anticonvulsant and anti-inflammatory activity — 2-chloro-1,3-benzothiazole is condensed with hydrazine hydrate (80% aqueous, 3.5 molar equivalents) in refluxing ethanol (95%) for 5–7 h under nitrogen. The chlorinated starting material is initially dissolved at 50°C at a concentration of 1.0 mol/L; after hydrazine addition, the mixture is heated to gentle reflux (78−80°C). Conversion is monitored by HPLC until the 2-Cl-BT peak area falls below 0.1%. The resulting solution is concentrated to half volume under vacuum at 45°C, cooled to 0–5°C, and the crystalline 2-hydrazinylbenzothiazole is isolated by filtration, washed with cold ethanol, and vacuum-dried at 40°C. Typical yield is 82–88%; purity by HPLC area % exceeds 99.5%, with residual hydrazine quantified by derivatisation-GC (<10 ppm) and chloride content by ion chromatography <200 ppm. As a key starting material for active pharmaceutical ingredient (API) synthesis under ICH Q7 Good Manufacturing Practice, the lot must be accompanied by a certificate of analysis detailing residual solvents (ethanol <5,000 ppm, isopropanol <500 ppm) per ICH Q3C and heavy metals (<10 ppm Pb, <2 ppm As, <1 ppm Cd) by ICP-MS. The compound is further reacted with α-bromoketones in the presence of triethylamine to furnish triazolo[3,4-b]benzothiazoles, which have been evaluated as CRF1 receptor antagonists. For supply into the European market, the manufacturing site must hold a valid EU GMP Part II certification; the shipment is controlled under a Technical Active Substance Master File (ASMF) with an open part complying with EMA/CHMP/QWP/227/02. Because 2-chlorobenzothiazole is sensitive to moisture and releases HCl upon hydrolysis, the warehousing of the raw material requires relative humidity <30% and storage in original 25 kg HDPE drums with desiccant bags. The hydrazine condensation is safely conducted in a 500 L glass-lined reactor with a rupture disc rated at 0.6 MPa and a dedicated scrubber for ammonia vapours. If Ammonia Amination Precedes Diazotization, a Cationic Red Azo Dye of High Tinctorial Strength Is ObtainedWhen 2-chloro-1,3-benzothiazole is first converted to 2-aminobenzothiazole by treatment with 25% aqueous ammonia (molar ratio NH3 : 2-Cl-BT ≈ 5:1) in the presence of cupric chloride dihydrate (0.05 mol %) at 120°C and 1.2 MPa in a 1,000 L Hastelloy autoclave for 8 h, the isolated 2-aminobenzothiazole (m.p. 126–128°C, purity >99.0%) serves as the diazo component. Diazotization is carried out in 25% sulfuric acid at 0–5°C with sodium nitrite (1.02 equivalents), and the resulting diazonium salt is coupled with N,N-diethylaniline (1.0 equivalent) dissolved in 10% acetic acid at pH 3.5–4.0. The coupling mass is stirred for 3 h at 10°C, neutralised with sodium acetate, and filtered; the wet cake is washed chloride-free and dried at 60°C to yield a dark red powder characterised by λmax 522 nm in methanol and an extinction coefficient > 3.5×104 L mol⁻¹ cm⁻¹. This cationic benzothiazole azo dye is applied for acrylic fibre dyeing in a bath set at pH 4.5–5.5 using 1.0–2.0% o.w.f., giving bright bluish-red shades with light fastness 5–6 (ISO 105-B02) and washing fastness 4–5 (ISO 105-C06). Dyes of this structural family must comply with Regulation (EC) No 1907/2006 Annex XVII Entry 43 on azocolourants, meaning that no reductive cleavage of the azo bond must liberate any of the 22 listed carcinogenic aromatic amines upon testing per EN 14362-1:2017; the absence of 4-aminobiphenyl, benzidine, and 2-naphthylamine is confirmed by GC-MS at reporting limits <30 mg/kg. For textile articles placed on the EU market, compliance with OEKO-TEX Standard 100 (product class I) imposes further restrictions on quinoline (<50 mg/kg) and extractable heavy metals. The intermediate 2-aminobenzothiazole is considered a potential skin sensitiser; thus, the dye synthesis operation mandates closed transfer systems and area monitoring for airborne concentrations <0.1 mg/m³ (8h TWA). |
Competitive 2-Chloro-1,3-Benzothiazole prices that fit your budget—flexible terms and customized quotes for every order.
For samples, pricing, or more information, please call us at +8615651039172 or mail to sales9@bouling-chem.com.
We will respond to you as soon as possible.
Tel: +8615651039172
Email: sales9@bouling-chem.com
Flexible payment, competitive price, premium service - Inquire now!
The most common industrial benzothiazoles—2-mercaptobenzothiazole (CAS 149-30-4) and its oxidation product 2,2'-dithiobis(benzothiazole) (CAS 120-78-5)—are consumed at scale as primary and secondary vulcanization accelerators. Their thiol and disulfide groups initiate radical cleavage and sulphur crosslinking in diene elastomers. By contrast, 2-chloro-1,3-benzothiazole possesses a C–Cl bond with a bond dissociation energy of approximately 402 kJ/mol, far above the S–S bond energy of ~230 kJ/mol in the disulfide analogue. This difference renders the chloro derivative inert under typical rubber compounding temperatures of 140–180 °C, making it unattractive as an accelerator. Its value resides instead in the formal oxidation state of the C-2 carbon, which is electrophilic enough to undergo oxidative addition to Pd(0) yet robust enough to survive ambient storage without dimerization. The following table summarizes key physical and reactivity contrasts between 2-chloro-1,3-benzothiazole and its structurally adjacent benzothiazole derivatives.
| Property | 2-Chloro-1,3-benzothiazole | 2-Bromobenzothiazole | 2-Mercaptobenzothiazole (MBT) |
|---|---|---|---|
| CAS | 615-20-3 | 2515-23-7 | 149-30-4 |
| Physical state at 25 °C | Liquid (mp 24–26 °C) | Low-melting solid (mp 42–44 °C) | Crystalline powder (mp 177–181 °C) |
| Typical commercial purity | ≥99.0% (GC) | ≥98.5% (GC) | ≥99.0% (titration, ASTM D 5671) |
| C–X bond dissociation energy (approx.) | 402 kJ/mol | 285 kJ/mol | — (thione-thiol tautomer, no discrete C–X measured) |
| Primary industrial use | Pharmaceutical & agrochemical intermediate | Same, but higher reactivity enables milder coupling conditions | Rubber vulcanization accelerator |
| Odor profile | Faintly aromatic | Pungent aromatic | Strong, persistent mercaptan odor |
| Storage requirement | Dry N₂ blanket, ≤30 °C | Dry N₂ blanket, ≤5 °C recommended to suppress decomposition | Ambient, amine-free atmosphere |
The bromo analogue reacts with Pd(0) at room temperature within 30–60 min, whereas 2-chloro-1,3-benzothiazole typically requires 80–100 °C under an inert atmosphere for complete conversion when using conventional Pd(PPh₃)₄ systems. This kinetic gap dictates a different manufacturing equipment envelope: the chloro compound permits use of standard glass-lined reactors with hot-water jacket capability, while the bromo derivative’s exothermic profile at low temperatures often demands brine-cooled reaction calorimetry to avoid thermal runaway. Additionally, MBT is incompatible with amine-based curatives and can generate N-nitrosamines under certain conditions; the chloro substituent remains chemically silent in such environments, a critical advantage when designing amine-functionalized scaffold libraries.
End-users in pharmaceutical synthesis demand a tightly controlled impurity profile to satisfy ICH Q3A thresholds for starting materials. The following release specification table is observed across multiple qualified producers, reflecting data acquired from over 120 consecutive commercial batches across three manufacturing sites. Deviation beyond the warranted limits triggers a root-cause investigation under the receiving site’s corrective and preventive action (CAPA) system.
| Parameter | Specification | Analytical Method |
|---|---|---|
| Assay | ≥99.0% (area %) | GC-FID, DB-5 column, 30 m × 0.32 mm × 0.25 µm |
| Individual identified impurity (2-hydroxybenzothiazole) | ≤0.30% | HPLC-UV at 254 nm, C18, 250 × 4.6 mm, 5 µm |
| Total unidentified impurities | ≤0.50% | GC-FID (as above) |
| Water content | ≤0.15% | Karl Fischer coulometric titration, ASTM D 6304-16e1 |
| Chloride ion (free HCl) | ≤150 ppm | Ion chromatography, ASTM D 4327-17 |
| Color (APHA) | ≤50 | ASTM D 1209-05 (2019) |
| Non-volatile residue | ≤0.05% | Gravimetric after 110 °C drying, 2 h |
Moisture intrusion directly elevates 2-hydroxybenzothiazole content through hydrolysis, with a rate constant that accelerates above 60% relative humidity. The chloride ion limit is especially critical for downstream Pd-catalyzed couplings: free HCl at concentrations above 200 ppm has been observed to protonate phosphine ligands, stripping active catalyst and reducing turnover numbers by up to 40% in a model Suzuki–Miyaura reaction with phenylboronic acid. Therefore, shipment of 2-chloro-1,3-benzothiazole under a 50–150 mbar nitrogen overlay in HDPE drums with PTFE-lined closures has become a standard quality assurance measure, verified by pressure-hold testing before dispatch. Residual solvents conform to ICH Q3C (R8) options for Class 3 solvents, with a typical total residual below 0.02%, predominantly ethyl acetate.
Within the synthetic route to a leading commercial herbicide, the installation of a biaryl motif via Suzuki–Miyaura coupling using 2-chloro-1,3-benzothiazole and a sterically hindered boronic ester has been scaled to a 4000 L glass-lined reactor equipped with a retreat-curve impeller and turbidity-based endpoint monitoring. The process operates at 75 ± 3 °C in a toluene/water biphasic system with K₃PO₄ as base. The chloro electrophile is charged as a melt, maintained at 30 °C in jacketed dosing lines to prevent solidification. Catalyst loading of Pd(OAc)₂ at 0.05 mol% paired with the dialkylbiaryl phosphine ligand SPhos (0.11 mol%) achieves 92% conversion within 8 h, with a final isolated yield after crystallization of 87%.
When the analogous 2-bromobenzothiazole was evaluated during process development, identical conditions gave complete conversion in 2 h at 25 °C. However, the bromo intermediate cost was 2.7-fold higher per kilogram on a bulk-contract basis, and its exothermic onset temperature by accelerating rate calorimetry (ARC) was 48 °C, compared to 112 °C for the chloro compound. This placed the bromo variant uncomfortably close to the maximum jacket temperature of the plant’s tempered water system, requiring an expensive retrofit to a dedicated brine loop. The C–Cl bond therefore functions as an in-built thermal safety margin: its higher thermal stability allows a wider processing window without sacrificing atom economy. The advantage is most pronounced in continuous flow reactors employing silicon carbide microchannels, where residence times of 4–6 min at 150 °C are attainable with the chloro derivative, achieving 93% conversion with a Pd envelope catalyst, a throughput impossible with the bromo analogue due to rapid catalyst deactivation via palladium black formation at elevated temperatures.
For manufacturers operating multi-purpose plants, the switch from bromo to chloro electrophile translates to a documented reduction from class 3 to class 1 process safety evaluation (Stoessel criticality class) for the same coupling, owing entirely to the elevated decomposition onset and lower heat flow. This classification directly impacts insurance premiums and risk management documentation filed under SEVESO III directives.
For manufacturing sites that require a liquid benzothiazole intermediate compatible with automated dispensing systems, 2-chloro-1,3-benzothiazole offers a practical advantage over solid alternatives that must be manually scooped from drums. Because its melting point of 24–26 °C lies slightly above typical warehousing temperatures in temperate climates, bulk storage vessels are fitted with low-intensity electrical heat tracing rated at 15 W/m and regulated by a PID controller with a setpoint of 30 °C. Recirculation loops with positive-displacement gear pumps maintain homogeneity and prevent localized crystallization in dead legs. The material is then dispensed through mass-flow meters into pre-weighed, nitrogen-filled reaction vessels. This infrastructure eliminates exposure to ambient humidity during transfers. In plants where such heated storage is not feasible, tote bins are kept in temperature-controlled cabinets at 28 ± 2 °C, and unloading is performed within 4 h to stay below the hydrolysis induction period. Hydrolysis kinetics data at 25 °C and 50% RH indicate that 2-hydroxybenzothiazole concentration increases by 0.12% per 6 h of atmospheric contact; therefore, any open-vessel transfer exceeding 2 h triggers an in-process Karl Fischer check. These constraints are particularly relevant when the subsequent reaction step demands a moisture specification tighter than 50 ppm, as encountered in lithium amide-based couplings forming the core of certain kinase inhibitors.Several generic active pharmaceutical ingredient (API) routes require 2-aminobenzothiazole as a scaffold fragment. Procuring this intermediate commercially in multi-tonne quantities exposes the supply chain to variability in residual ammonium salts and regioisomeric contamination originating from the traditional cyclization of thiourea with an aryl amine. An increasing number of API manufacturers have migrated to an on-demand synthesis, reacting 2-chloro-1,3-benzothiazole with ammonia in a pressure autoclave at 130–150 °C and 10–15 bar. The conversion is quantitative, and the resulting 2-aminobenzothiazole can be isolated by simple aqueous wash and crystallization, eliminating trace chloride using a sodium bicarbonate quench. This approach yields a product with a purity exceeding 99.8% (HPLC, 254 nm) and a melting point of 129–131 °C, matching both Ph. Eur. and USP monograph standards for the substance. The C–Cl to C–NH₂ transformation bypasses the genotoxic impurity risk associated with residual aniline-derived byproducts present in conventionally sourced material, a critical benefit for ICH M7 risk assessment. A single 2000 L high-pressure reactor can produce 180 kg of 2-aminobenzothiazole per batch, decoupling the downstream API schedule from fluctuations in the fine chemical merchant market. This captive-use scenario repositions 2-chloro-1,3-benzothiazole from a simple intermediate to a strategic chain-extending synthon.
2-Chloro-1,3-benzothiazole is registered under REACH with EC number 210-406-2, and its dossiers include a full read-across to benzothiazole toxicological endpoints. Under the UN Globally Harmonized System, it is classified as Acute Toxicity Category 4 (oral, H302), Skin Corrosion/Irritation Category 2 (H315), Serious Eye Irritation Category 2 (H319), and Aquatic Chronic 3 (H412). Transport labeling conforms to UN 3082, Environmentally Hazardous Substance, Liquid, N.O.S., Packing Group III. For shipments within the European Union, the material must be accompanied by a safety data sheet compliant with Regulation (EC) No 1907/2006, Annex II as amended. When the destination jurisdiction exempts chlorinated aromatics from specific packing certifications, an IATA/IMDG dangerous goods declaration is generated listing the PG III and the emergency response guide number 171. In multi-purpose plant changeover procedures, dedicated lines for 2-chloro-1,3-benzothiazole are strongly recommended after a campaign producing amine-based products, as residual primary amines react exothermically even at ambient temperature to form complex adducts, compromising the integrity of subsequent batches. Cleaning validation protocols using swab analysis by LC-MS with a detection limit of 1 ng/cm² are typically applied, as specified in PIC/S PI 006-4 heritage documents.